CYP1A2, a key enzyme in the cytochrome P450 family, plays a vital role in the metabolism of various substances in the human body, including drugs and environmental chemicals. This enzyme is particularly important for pharmacokinetics, as it can influence drug efficacy and safety. At IPHASE, we recognize the significance of CYP1A2 in drug development and have dedicated our efforts to providing high-quality research tools and kits that support scientific advancements in this area.
Founded with a commitment to excellence, IPHASE initially launched its first ADME products tailored for early drug screening. Our continuous investment in research and development has allowed us to expand our product portfolio significantly. We now offer a diverse range of high-quality products designed for pharmacokinetics, pharmacology, microbiology, immunology, genetics, and clinical medicine. Each product is meticulously produced and validated according to recognized international standards, including OECD and ICH guidelines.
Among our extensive offerings, you'll find specialized kits such as the High-Quality IPHASE Dog (Beagle) Skin S9 Fraction kit . This kit is designed for researchers looking to study pharmacokinetics in animal models, providing comprehensive data on how CYP1A2 interacts with various substances. Similarly, our High-Quality IPHASE Human Kidney Tissue kit aids in examining drug metabolism in human tissues, allowing researchers to delve deeper into the role CYP1A2 plays in drug interactions and overall efficacy.
Moreover, our product line includes unique offerings such as the High-Quality IPHASE Duck Serum, Single Donor, Male kit and the High-Quality IPHASE Rat (Sprague-Dawley) PPB Plasma, EDTA-K2 kit . These kits are essential for researchers who need reliable animal-derived materials to understand the impact of CYP1A2 on drug metabolism across different species. By providing validated and high-quality samples, IPHASE empowers scientists to conduct intricate studies that contribute to safer and more effective drug therapies.
Our dedication to quality is further exemplified by our High-Quality IPHASE Mouse (ICR/CD-1) Kidney Microsome kit , designed specifically to aid in studying the metabolic pathways involving CYP1A2 in mouse models. The insights gained from these studies are crucial, as they help bridge the gap between preclinical findings and clinical applications. Additionally, our High-Quality IPHASE Mouse (C57BLN/A6) Bile, Single Donor, Male kit serves to investigate bile composition and metabolism, offering further understanding of how CYP1A2 influences various biological processes.
At IPHASE, we pride ourselves not only on the quality of our products but also on the extensive after-sales support we provide. Our team of experts is available to assist clients with any inquiries regarding our products, ensuring that researchers can make the most of the tools we offer in their vital work.
In conclusion, CYP1A2 is an essential enzyme that significantly affects drug metabolism and pharmacokinetics. At IPHASE, we are committed to providing high-quality, validated products that support research and drive innovation in the scientific community. We invite researchers and institutions to explore our extensive offerings and discover how IPHASE can contribute to their understanding of CYP1A2 and its implications in drug development and safety.
